(NASDAQ: IDXX) Idexx Laboratories's forecast annual revenue growth rate of 7.04% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.
Idexx Laboratories's revenue in 2025 is $4,037,715,000.On average, 6 Wall Street analysts forecast IDXX's revenue for 2025 to be $338,564,744,121, with the lowest IDXX revenue forecast at $336,115,720,433, and the highest IDXX revenue forecast at $340,019,949,500. On average, 7 Wall Street analysts forecast IDXX's revenue for 2026 to be $364,932,851,179, with the lowest IDXX revenue forecast at $352,500,681,764, and the highest IDXX revenue forecast at $370,885,760,445.
In 2027, IDXX is forecast to generate $397,211,945,043 in revenue, with the lowest revenue forecast at $384,022,531,200 and the highest revenue forecast at $404,231,716,904.